Success Metrics

Completion Rate
0%(0/2)
Active Trials
2(40%)
Terminated
2(40%)

Phase Distribution

Ph phase_1
1
20%
Ph early_phase_1
2
40%
Ph phase_3
1
20%
Ph phase_4
1
20%

Phase Distribution

3

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(3)

Detailed Status

Recruiting2
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (40.0%)
Phase 11 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)

Trials by Status

recruiting240%
terminated240%
withdrawn120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_3

Repurposing Low-Dose Clonidine for PTSD in Veterans

NCT04877093
recruitingphase_1

Mitigating the Pro-inflammatory Phenotype of Obesity

NCT04934228
terminatedphase_4

Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System

NCT03109795
withdrawnearly_phase_1

PET Study of a2a Agonist Effects on the Ventricular CSF Clearance of [11C]Butanol

NCT04032691
terminatedearly_phase_1

Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies

NCT04030572

Clinical Trials (5)

Showing 5 of 5 trials
NCT04877093Phase 3

Repurposing Low-Dose Clonidine for PTSD in Veterans

Recruiting
NCT04934228Phase 1

Mitigating the Pro-inflammatory Phenotype of Obesity

Recruiting
NCT03109795Phase 4

Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System

Terminated
NCT04032691Early Phase 1

PET Study of a2a Agonist Effects on the Ventricular CSF Clearance of [11C]Butanol

Withdrawn
NCT04030572Early Phase 1

Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5